1. From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis
Ann Intern Med. 2012;157(4): doi: /
Figure Legend:
* Data from reference 11.
Date of download: 10/6/2017
Copyright © American College of Physicians. All rights reserved.

2. From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis
Ann Intern Med. 2012;157(4): doi: /
Figure Legend:
* “Subsets” refers to the presence of data from subgroups of patients with CKD not receiving dialysis or cohorts receiving various types of dialysis (peritoneal dialysis or hemodialysis) within broader trials.
Date of download: 10/6/2017
Copyright © American College of Physicians. All rights reserved.

3. From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis
Ann Intern Med. 2012;157(4): doi: /
Figure Legend:
* “Subsets” refers to subgroups of persons with differing stages of CKD within a single trial for which disaggregated outcome data could be included in the analyses.
Date of download: 10/6/2017
Copyright © American College of Physicians. All rights reserved.

4. From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis
Ann Intern Med. 2012;157(4): doi: /
Figure Legend:
* “Explained variance” refers to the proportion of variance in the overall treatment effect estimate explained by stage of chronic kidney disease.
Date of download: 10/6/2017
Copyright © American College of Physicians. All rights reserved.

5. From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis
Ann Intern Med. 2012;157(4): doi: /
Figure Legend:
* “Explained variance” refers to the proportion of variance in the overall treatment effect estimate explained by stage of chronic kidney disease.
Date of download: 10/6/2017
Copyright © American College of Physicians. All rights reserved.

6. From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis
Ann Intern Med. 2012;157(4): doi: /
Figure Legend:
Risk of bias in trials comparing statin regimens with placebo or no treatment.
Date of download: 10/6/2017
Copyright © American College of Physicians. All rights reserved.